COMMUNIQUÉS West-GlobeNewswire

Visual Healthcare Corp. Announces Shareholder Update
19/03/2019
New Management, No Reverse Split, and Dynamic Business Plan Lead Turnaround Efforts HOUSTON, TX, March 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Visual Healthcare Corp. (OTC PINK: VSHC) announces it has been [...]
Pulse8 joins the Health Plan Alliance Group Purchasing Organization with its ground-breaking Formul8™ solution for managing Pharmacy Costs
19/03/2019
NASHVILLE, March 19, 2019 (GLOBE NEWSWIRE) -- Pulse8, part of Veradigm™, an Allscripts (NASDAQ: MDRX) business unit, the first – and ONLY one with a patent pending – healthcare analytics and technology company [...]
Synthorx to Present at the American Association of Cancer Research (AACR) Annual Meeting 2019
19/03/2019
SAN DIEGO, March 19, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (NASDAQ: THOR), a biotechnology company using a first-of-its-kind Expanded Genetic Alphabet platform technology to discover and develop optimized biologics [...]
Spero Announces Appointment of Cynthia Smith to its Board of Directors
19/03/2019
Spero adds significant commercial leadership and product launch expertise to its Board of Directors with appointment of Cynthia Smith CAMBRIDGE, Mass., March 19, 2019 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq [...]
Better Choice Company Announces the Appointment of Former CPG-Executive Jeff Davis to Board of Directors
19/03/2019
NEW YORK, March 19, 2019 (GLOBE NEWSWIRE) -- Better Choice Company, Inc (OTCQB: BTTR) (OTCQB: BTTRD) (the “Company”) announced today the appointment of Jeff Davis to the Company’s Board of Directors. Jeff is the Founder [...]
ComplyAssistant and Furnace Brook HealthCare Management Advisors Team Up to Offer Enterprise Compliance Program Solutions
19/03/2019
ISELIN, N.J. and CROTON-ON-HUDSON, N.Y., March 19, 2019 (GLOBE NEWSWIRE) -- ComplyAssistant, located in Iselin, NJ, and Furnace Brook HealthCare Management Advisors, located in Croton-on-Hudson, NY announce a [...]
Tabula Rasa HealthCare’s SinfoníaRx Publishes Comprehensive 2019 Medication Therapy Management Program Performance Report
19/03/2019
Year-Over-Year Proficiencies and Growth Documented in Comprehensive Annual Report MOORESTOWN, N.J., March 19, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC), a healthcare technology [...]
Biotricity Announces Expanded R&D Team for the Development of its Fetal/Maternal and Ambulatory Wellness Monitoring Systems
19/03/2019
REDWOOD CITY, Calif., March 19, 2019 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB : BTCY ), a medical diagnostic and consumer healthcare technology company, is pleased to announce further buildout of its R&D team, [...]
PhaseBio To Report Fourth Quarter and Full-Year 2018 Financial and Business Results on March 26, 2019
19/03/2019
MALVERN, Pa. and SAN DIEGO, March 19, 2019 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel [...]
Zogenix Enters Exclusive Distribution Agreement with Nippon Shinyaku for FINTEPLA® in Japan
19/03/2019
EMERYVILLE, Calif., March 19, 2019 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq: ZGNX), a global pharmaceutical company developing rare disease therapies, today announced that it has entered into an exclusive distribution [...]
Aeterna Zentaris to Announce Fourth Quarter and Year End 2018 Financial and Operating Results on March 26, 2019
19/03/2019
CHARLESTON, S.C., March 19, 2019 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) will announce its fourth quarter and year ended December 31, 2018 financial and operating results after market close [...]
Inhibikase Therapeutics Expands its Scientific Advisory Board with the Appointment of Leading Experts in Parkinson’s Disease
19/03/2019
ATLANTA and BOSTON, March 19, 2019 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc., a pharmaceutical company developing protein kinase inhibitors for the treatment of neurological infections and neurodegenerative [...]
Innovative Cellular Therapeutics Announces Successful Completion of Pre-IND Meeting With FDA
19/03/2019
ROCKVILLE, Md., March 19, 2019 (GLOBE NEWSWIRE) -- Innovative Cellular Therapeutics (ICT), a biotechnology company developing cellular immunotherapies for the treatment of cancer, today announced it has successfully [...]
MédecinDirect rejoint le groupe international Teladoc Health
19/03/2019
Grâce à cette nouvelle implantation locale en France, Teladoc Health propose désormais une offre complète de services aux assureurs et aux employeurs sur le troisième marché européen. NEW YORK, PARIS, 19 mars 2019 ( [...]
Blueberries Medical Appoints Former Colombian Minister & Ambassador Fabio Valencia to Board of Directors
19/03/2019
Appointment Adds Extensive International Commercial Expertise and Further Expands Strategic Relationships within South America and the European Union TORONTO, March 19, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp [...]
Teladoc Health to Expand Global Reach with Acquisition of MédecinDirect
19/03/2019
With strong local French presence, Teladoc Health now to offer its full continuum of services to insurers and employers in Europe’s third largest market PURCHASE, NY and PARIS, March 19, 2019 (GLOBE NEWSWIRE) -- Teladoc [...]
Micron Solutions, Inc. Reports 2018 Fourth Quarter and Year End Results
19/03/2019
FITCHBURG, Mass., March 19, 2019 (GLOBE NEWSWIRE) -- Micron Solutions, Inc. (NYSE American: MICR) (the “Company”), a diversified contract manufacturing organization, through its wholly-owned subsidiary, Micron Products [...]
Innovate Biopharmaceuticals Reports Financing to Initiate the First Phase 3 Clinical Trial in Celiac Disease, Fiscal Year 2018 Earnings and Key Corporate Highlights
19/03/2019
Innovate closes an equity financing with gross proceeds of $9.7 million Continued launch activities for start of the first Phase 3 celiac disease trial, expected to start Q2 2019 Continued research collaborations [...]
ProMIS Neurosciences to Present Data for Potential Best-in-Class Antibody Candidates for Parkinson’s Disease at AD/PD™ 2019 Conference
19/03/2019
Selected for podium presentation: novel antibody candidates bind only the toxic species of alpha-synuclein offering potential advantages over less selective therapies in development TORONTO and CAMBRIDGE, Mass., March [...]

Pages